Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.
about
NETosis in Cancer - Platelet-Neutrophil Crosstalk Promotes Tumor-Associated PathologyThe Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory TherapyDirected Chemical Evolution with an Outsized Genetic CodeInhibition of NET Release Fails to Reduce Adipose Tissue Inflammation in MiceHistones as mediators of host defense, inflammation and thrombosisLupus and proliferative nephritis are PAD4 independent in murine models.Chemical probes targeting epigenetic proteins: Applications beyond oncology.ATAC-see reveals the accessible genome by transposase-mediated imaging and sequencing.PAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shockChemical biology of protein arginine modifications in epigenetic regulationDNA-Encoded Solid-Phase Synthesis: Encoding Language Design and Complex Oligomer Library SynthesisProtein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design.DNA-encoded chemical libraries: foundations and applications in lead discovery.Diabetes primes neutrophils to undergo NETosis, which impairs wound healing.NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation.Neutrophil elastase-deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis.Protein Arginine Methylation and Citrullination in Epigenetic RegulationNeutrophil extracellular traps - the dark side of neutrophils.Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses.Priming of neutrophils toward NETosis promotes tumor growth.Neonatal NET-inhibitory factor and related peptides inhibit neutrophil extracellular trap formation.Evolution of a mass spectrometry-grade protease with PTM-directed specificity.The role of extracellular histone in organ injury.PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.Neutrophil extracellular traps: protagonists of cancer progression?Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory responseNETs in cancer.Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma.Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis.NETopathies? Unraveling the Dark Side of Old Diseases through Neutrophils.A Critical Reappraisal of Neutrophil Extracellular Traps and NETosis Mimics Based on Differential Requirements for Protein Citrullination.Neutrophil-mediated vascular barrier injury: Role of neutrophil extracellular traps.Neutrophil Extracellular Traps and Its Implications in Inflammation: An OverviewAn emerging role for neutrophil extracellular traps in noninfectious disease.Diverse stimuli engage different neutrophil extracellular trap pathways.The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris.PAD4 Deficiency Decreases Inflammation and Susceptibility to Pregnancy Loss in a Mouse Model.Tumor-induced neutrophil extracellular traps-drivers of systemic inflammation and vascular dysfunction.Cl-Amidine Prevents Histone 3 Citrullination and Neutrophil Extracellular Trap Formation, and Improves Survival in a Murine Sepsis Model.NETosis in cancer.
P2860
Q28066483-7EFB06C0-115A-412B-B593-73C9D10817A4Q28077916-A8AB2001-BB50-4FFE-817E-4125757CEF46Q28553436-5B84D345-137E-4481-9EF3-7523B2E50A97Q28554463-BA07BC3F-B2A4-43B7-ADE9-052F12D7AAD3Q33430482-FE3CD902-B663-4EF9-A65F-34C19050254EQ33703196-0E90FE88-8E78-4D46-BDA6-DB33D6B0A225Q33751386-0FAB1DE8-3182-41EF-B083-02CACDD9827BQ33902636-32A8879A-01B6-4C32-8F2F-3227357D3C47Q35197441-DE48A3F5-1DBA-4266-AB46-06D52D2CACAFQ35722457-62AD00B2-9B1D-4671-ABEE-FB9F20DBA073Q35750869-6B4CB4A1-0330-44E8-A213-F326344B6019Q36057948-0ED0D0D5-5D1B-468A-B697-1BFE2C2ACDA4Q36091299-2C7D5DD2-D691-4940-9256-67D7089C023EQ36243461-A8EB7F54-4462-4B25-8F98-D337C45FE878Q36625405-5B06F8A4-F275-45EB-B22D-6E58673E51B3Q36669655-7AED62E4-98DD-4E34-9C97-298034866BD9Q36713555-401CE408-EDB4-480C-9E99-3F6F6BC6A593Q36867309-2E1ADC78-F22D-4FE9-A2C3-A29DB49AA027Q36925292-4A0269DD-E4F6-4DC0-AE70-51BE99E156D4Q37012590-21BD546D-44B3-4EA8-B910-5689A4326778Q37395688-0C6D5B78-EF50-47D9-BFA4-0EB38C8DDDDCQ37534355-D8C4FE31-8BCE-4B61-8C27-DAEA2EFC73AAQ38679240-F4189CFB-D64C-4429-A74E-B87BDE69EDBBQ38747640-2354B9A6-5E92-465E-BC55-DFBB8392868EQ38784271-2AAE20F9-F007-4758-B9CC-F4DA0CDD6C1FQ38785264-32038886-4A25-435F-9061-D24F10CF0C89Q38950988-47151E41-6A7F-4AF2-8CAC-3B3DCC351DF3Q38978681-870AB921-17A5-4E8A-BFDF-372C79C1C2B3Q38995539-03539D35-4BD5-41F3-BD36-F9E93C09DD08Q38998709-1E9CFFDD-59B0-425C-BE11-35B8B47BA8D0Q39014892-C5686AC6-397F-4552-9D61-EA9EF68E8161Q39102339-6E6E9B1F-C6A6-42A6-8A9A-494DFC3125C1Q39144786-11351B59-4BA5-4BB1-B78E-6E0A53969D6EQ39166302-F59D4A49-4BF2-4E54-9AA9-C47C77E0BBA1Q40187829-57FA0DA3-E8FA-4357-9019-BE8FD241C231Q40248462-E8300D33-7CC2-4796-9146-2B7EEF2FA490Q40398309-034E813A-BC40-4473-A35C-1C1198BBAEE7Q40436394-D591E58D-96E7-460D-BF48-4AA7AE7D7D03Q40542138-D73CAD96-C3DC-4EEF-BBB6-7217958EF7D5Q41832117-699A67F4-1A14-4CE8-A0BF-E97977BA4A49
P2860
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.
@ast
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.
@en
type
label
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.
@ast
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.
@en
prefLabel
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.
@ast
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.
@en
P2093
P2860
P50
P356
P1476
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation
@en
P2093
Cecil E Rise
Chris Patten
Chun-Wa Chung
Claire Maller
David M Wilson
Denisa D Wagner
Dirk Eberhard
Gerard Joberty
Huw D Lewis
P2860
P2888
P304
P356
10.1038/NCHEMBIO.1735
P577
2015-01-26T00:00:00Z